NCT03834857View on ClinicalTrials.gov

SWITCH: Stentrode First-in-Human Study of Implantable BCI for Control of a Digital Device

NACompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

May 27, 2019

Primary Completion Date

December 10, 2021

Study Completion Date

January 9, 2022

Conditions
Neurologic Disorder
Interventions
DEVICE

Stentrode

Implantation of Stentrode device

Trial Locations (1)

3050

Royal Melbourne Hospital, Melbourne

All Listed Sponsors
lead

Synchron Australia Pty Ltd.

INDUSTRY

NCT03834857 - SWITCH: Stentrode First-in-Human Study of Implantable BCI for Control of a Digital Device | Biotech Hunter | Biotech Hunter